4-(8-Oxo-8-phenylaminooctanamidooxymethyl)phenyl methyl-2-(methyl-2-phenylcyclopropylamino)ethylcarbamate

ID: ALA5174314

Chembl Id: CHEMBL5174314

PubChem CID: 132821245

Max Phase: Preclinical

Molecular Formula: C35H44N4O5

Molecular Weight: 600.76

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(CCN(C)C1CC1c1ccccc1)C(=O)Oc1ccc(CONC(=O)CCCCCCC(=O)Nc2ccccc2)cc1

Standard InChI:  InChI=1S/C35H44N4O5/c1-38(32-25-31(32)28-13-7-5-8-14-28)23-24-39(2)35(42)44-30-21-19-27(20-22-30)26-43-37-34(41)18-12-4-3-11-17-33(40)36-29-15-9-6-10-16-29/h5-10,13-16,19-22,31-32H,3-4,11-12,17-18,23-26H2,1-2H3,(H,36,40)(H,37,41)

Standard InChI Key:  YIJJVUYQBWQCRG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5174314

    ---

Associated Targets(Human)

KDM1A Tchem Lysine-specific histone demethylase 1 (3916 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H526 (216 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HMEC (560 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 600.76Molecular Weight (Monoisotopic): 600.3312AlogP: 6.13#Rotatable Bonds: 17
Polar Surface Area: 100.21Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.58CX Basic pKa: 7.97CX LogP: 5.24CX LogD: 4.89
Aromatic Rings: 3Heavy Atoms: 44QED Weighted: 0.14Np Likeness Score: -0.70

References

1. Ota Y, Itoh Y, Kurohara T, Singh R, Elboray EE, Hu C, Zamani F, Mukherjee A, Takada Y, Yamashita Y, Morita M, Horinaka M, Sowa Y, Masuda M, Sakai T, Suzuki T..  (2022)  Cancer-Cell-Selective Targeting by Arylcyclopropylamine-Vorinostat Conjugates.,  13  (10.0): [PMID:36262394] [10.1021/acsmedchemlett.2c00126]

Source